Tolperisone

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the

ITIC 500MG

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

InformationScopine is the metabolite of anisodine, which is a α1-adrenergic receptor agonist and used in the treatment of acute circulatory shock.In vitroIn vivoCell Datacell lines：Concentrations：Incubation Time：Powder Purity:.

SOTALOL FOR SYSTEM SUITABILITY CRS EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD

TOFA 10mg

Tofacitinib

Tofacitinib

A selective, nonpeptide vasopressin V2 receptor antagonist (IC₅₀ = 3 nM) that has been shown to induce hypotonic diuresis without affecting the excretion of electrolytes in both animal and clinical models.

A selective, nonpeptide vasopressin V2 receptor antagonist (IC₅₀ = 3 nM) that has been shown to induce hypotonic diuresis without affecting the excretion of electrolytes in both animal and clinical models.

A selective, nonpeptide vasopressin V2 receptor antagonist (IC₅₀ = 3 nM) that has been shown to induce hypotonic diuresis without affecting the excretion of electrolytes in both animal and clinical models.

A selective, nonpeptide vasopressin V2 receptor antagonist (IC₅₀ = 3 nM) that has been shown to induce hypotonic diuresis without affecting the excretion of electrolytes in both animal and clinical models.